Coronavirus (COVID-19): visiting The Royal Marsden suspended

Coronavirus (COVID-19) latest: Visiting The Royal Marsden is still suspended, but we want to reassure our patients, their families and anyone worried about cancer during this difficult time that we are still delivering treatment - the hospital is open. Please see more information here about how we are keeping everyone safe.

Dr Susannah Stanway

Consultant in Medical Oncology MBChB MSc FRCP MD

Specialism: Breast

Available at: Sutton

Special interests:

  • All aspects of medical treatment of breast cancer 
  • Young women with breast cancer
  • Breast cancer survivorship
  • Cancer control in low- and middle- income countries
  • Acute Oncology

Biography

Dr Susannah Stanway is a Consultant in Medical Oncology in the Breast Unit at The Royal Marsden NHS Foundation Trust. Having qualified from Bristol University in 1998, she obtained an MD thesis for her work on Steroid Sulphatase Inhibition in postmenopausal patients with Breast Cancer from Imperial College in 2009; her oncology training was undertaken at UCLH and The Royal Marsden NHS Foundation Trust. She completed an MSc thesis for her work on risk stratification to guide follow up after childhood malignancy. She has been working at consultant level since 2012 and in 2018 was made a Fellow of the Royal College of Physicians. She is immediate past president of the Oncology Section at the Royal Society of Medicine.

Susie’s principle research and education interests center around cancer control in low-middle income countries. She sits on the editorial board of ASCO’s Journal of Global Oncology and leads a sub-module on Cancer in Low-Middle Income Countries on the Institute of Cancer Research’s MSc course. She actively contributes to oncology education of junior doctors by facilitating “train the trainers courses” in East Africa a partnership between the East African Development Bank, the British Council and the Royal College of Physicians. She has founded and chaired the steering group of the “Cancer Control in Low- and Middle- Income Countries” conference held annually at the Royal Society of Medicine for the last 4 years. She has received awards from the Global Challenges Research Fund to study unmet need in women following breast cancer treatment Ghana and Tanzania and subsequent related work. She is the founder and co-chair of the RM/ICR Cancer Control in Low- and Middle-Income Countries Collaborative Group focusing on collaborative research and education in low resource settings within the two institutions.

Susie is also actively involved in research and education around cancer survivorship. This includes the area of cardio-oncology, in collaboration with amongst others, the Cardio-Oncology Group at the Royal Brompton Hospital and the London School of Hygiene and Tropical Medicine (where she has recently co-supervised a PhD student); treatment-induced Hot Flushes (where she sits on the NCRI Symptom Management Working Group); In 2017 she co-chaired the Global Cardio-Oncology Summit in London; sexual and psychological consequences of cancer and has historically co-chaired the Royal Marsden NHS Foundation Trust’s Living With and Beyond Cancer Committee and sat on the Royal Marsden Partners Vanguard Survivorship pathway. She has set up a pan-London multi-disciplinary survivorship research group; she leads the Living with and Beyond Cancer Module on the ICR’s MSc course; and has been actively involved with the Royal Marsden NHS Foundation Trust’s Young Women’s Breast Cancer service since its inception.

She has spoken locally, nationally and internationally and has published in peer reviewed journals.

She is a member of the American Society of Clinical Oncology, the Royal College of Physicians, the Royal Society of Medicine, the British Breast Group, the Association of Cancer Physicians, British Cardio-oncology Society, European Society of Medical Oncology and British Medical Association.

 

Clinic units